Kiniksa whiffs on ef­fi­ca­cy try­ing to re­pur­pose an RA pro­gram for Covid-19, but spins sur­vival 'trend­s' as a pos­i­tive

As the search for more po­ten­tial Covid-19 treat­ments con­tin­ues, Kiniksa Phar­ma­ceu­ti­cals $KN­SA has re­vealed da­ta for a re­pur­posed im­munol­o­gy can­di­date it says are pos­i­tive. But …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER